The Immune Responsiveness in Hepatitis C Virus Infected Patients: Effects of Interferon-Alfa / Ribavirin Combined Treatment on the Lymphocyte Response with Special Reference to B Cells
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2093-2100
Author(s):
L. Amati, R. Cozzolongo, O. G. Manghisi, R. Cuppone, N. M. Pellegrino, D. Caccavo and E. Jirillo
Artificial Neural Networks for the Prediction of Response to Interferon Plus Ribavirin Treatment in Patients with Chronic Hepatitis C
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2101-2109
Author(s):
P. A. Maiellaro, R. Cozzolongo and P. Marino
Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2111-2122
Author(s):
P. Fabris, E. Barnes, G. Tositti, M. T. Giordani, A. Grasso and F. de Lalla
The Impact of Antiviral Treatments on the Course of Chronic Hepatitis C: An Evidence-Based Approach
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2123-2130
Author(s):
Calogero Camma, Danilo Di Bona and Antonio Craxi
Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2131-2143
Author(s):
Enriquez P and Bullock R.
Importance of Aquaporins in the Physiopathology of Brain Edema
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2153-2161
Author(s):
Jose L. Venero, Alberto Machado and Josefina Cano
Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2177-2183
Author(s):
Anat Biegon
Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2185-2192
Author(s):
W. M. Armstead
Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2193-2204
Author(s):
J. Sahuquillo, M. P. Mena, A. Vilalta and M. A. Poca
The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2239-2248
Author(s):
K. Burgyone, K. Aduri, J. Ananth and S. Parameswaran